These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27006991)

  • 21. Dichloroacetate induces regulatory T-cell differentiation and suppresses Th17-cell differentiation by pyruvate dehydrogenase kinase-independent mechanism.
    Makita N; Ishiguro J; Suzuki K; Nara F
    J Pharm Pharmacol; 2017 Jan; 69(1):43-51. PubMed ID: 27757958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells.
    Zhang SL; Zhang W; Yang Z; Hu X; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():87-92. PubMed ID: 28347773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid residues responsible for the recognition of dichloroacetate by pyruvate dehydrogenase kinase 2.
    Klyuyeva A; Tuganova A; Popov KM
    FEBS Lett; 2007 Jun; 581(16):2988-92. PubMed ID: 17544412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity.
    Fang A; Luo H; Liu L; Fan H; Zhou Y; Yao Y; Zhang Y
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5450-5453. PubMed ID: 29150396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic modulation of glioblastoma with dichloroacetate.
    Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
    Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines.
    Harting TP; Stubbendorff M; Hammer SC; Schadzek P; Ngezahayo A; Murua Escobar H; Nolte I
    PLoS One; 2017; 12(6):e0178744. PubMed ID: 28591165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic targeting as an anticancer strategy: dawn of a new era?
    Pan JG; Mak TW
    Sci STKE; 2007 Apr; 2007(381):pe14. PubMed ID: 17426345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin Therapy Results in Mitigation of ATP Loss after Irradiation Combined with Wound Trauma: Preservation of Pyruvate Dehydrogenase and Inhibition of Pyruvate Dehydrogenase Kinase 1.
    Swift JM; Smith JT; Kiang JG
    Radiat Res; 2015 Jun; 183(6):684-92. PubMed ID: 26010714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
    Wu DM; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Chen GQ; Zheng YL
    Eur J Med Chem; 2019 Feb; 164():252-262. PubMed ID: 30597326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of pyruvate dehydrogenase kinase 1 in retinoblastoma: A potential therapeutic opportunity for targeting vitreous seeds and hypoxic regions.
    Sradhanjali S; Tripathy D; Rath S; Mittal R; Reddy MM
    PLoS One; 2017; 12(5):e0177744. PubMed ID: 28505181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
    Michelakis ED; Gurtu V; Webster L; Barnes G; Watson G; Howard L; Cupitt J; Paterson I; Thompson RB; Chow K; O'Regan DP; Zhao L; Wharton J; Kiely DG; Kinnaird A; Boukouris AE; White C; Nagendran J; Freed DH; Wort SJ; Gibbs JSR; Wilkins MR
    Sci Transl Med; 2017 Oct; 9(413):. PubMed ID: 29070699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of S6K1 enhances dichloroacetate-induced cell death.
    Hong SE; Shin KS; Lee YH; Seo SK; Yun SM; Choe TB; Kim HA; Kim EK; Noh WC; Kim JI; Hwang CS; Lee JK; Hwang SG; Jin HO; Park IC
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1171-9. PubMed ID: 25471732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming Energy Metabolism with Synthesized PDK Inhibitors Based on Dichloroacetate Derivatives and Targeted Delivery Systems for Enhanced Cancer Therapy.
    She W; Liu T; Li H; Wang Z; Guo Z; Liu Y; Liu Y
    J Med Chem; 2023 Nov; 66(21):14683-14699. PubMed ID: 37688544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters.
    Liu Y; Tian HY; Yan XL; Fan FL; Wang WP; Han JL; Zhang JB; Ma Q; Meng Y; Wei F
    Cardiovasc Pathol; 2013; 22(6):451-7. PubMed ID: 23601559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
    Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy.
    Wei G; Sun J; Luan W; Hou Z; Wang S; Cui S; Cheng M; Liu Y
    J Med Chem; 2019 Oct; 62(19):8760-8772. PubMed ID: 31509699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
    Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
    Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells.
    Vella S; Conti M; Tasso R; Cancedda R; Pagano A
    Int J Cancer; 2012 Apr; 130(7):1484-93. PubMed ID: 21557214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic mechanisms underlying X-linked Charcot-Marie-Tooth neuropathy (CMTX6) in patients with a pyruvate dehydrogenase kinase 3 mutation.
    Perez-Siles G; Ly C; Grant A; Drew AP; Yiu EM; Ryan MM; Chuang DT; Tso SC; Nicholson GA; Kennerson ML
    Neurobiol Dis; 2016 Oct; 94():237-44. PubMed ID: 27388934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluation.
    Yu M; Li P; Basnet SK; Kumarasiri M; Diab S; Teo T; Albrecht H; Wang S
    Eur J Med Chem; 2015 May; 95():116-26. PubMed ID: 25800647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.